Head and neck

Survival outcomes for head and neck cancer are dependent on site of disease as well as stage of disease at diagnosis and the patient's general health and fitness. Almost half of patients referred to The Christie with head and neck cancers have cancer of the pharynx. 77% of patients with pharyngeal cancer referred to The Christie survive at least one year following diagnosis.

This graph shows percentage survival for Head and Neck cancer patients referred to the Christie by site of disease:

Head & Neck Annual Report 2013/14

Further Head & Neck Outcomes Data

Last updated: March 2022

Christie stories during the COVID-19 pandemic

During the COVID-19 pandemic, we're doing all we can to make sure patients get the treatment, information and support they need. Read some stories from our patients and staff to find out what The Christie is doing at this difficult time.

View All
Corinne Faivre Finn
“We have seen a lot of our research staff return to the office. This has massively improved morale as it is a lot easier to connect with people.”
Corinne Faivre-Finn, Christie consultant
Read More
Read More
profile placeholder image
“The experience has allowed me to be able to hear what is not being said. The extraordinary strength and resilience of individuals as they greet you with a smile… when you are aware of the pain and anguish they will be going through.”
Digital services team, redeployed to telephone patients
Read More
Read More
“Of course, the COVID-19 virus has not gone away – we have to be cautious and we have to proceed in an appropriate way.”
Professor John Radford, director of research at The Christie
Read More
Read More